EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Mechanisms of GLP-1 in Modulating Craving and Addiction: Neurobiological and Translational Insights

Gabriel Amorim Moreira Alves iD, Masatoki Teranishi iD, Ana Claudia Teixeira de Castro Gonçalves Ortega, Frank James, Arosh S Perera Molligoda Arachchige iD

Medical Sciences · 15.08.2025 · 13 (3) · 136

DOI: 10.3390/medsci13030136 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Sciences, online erschienen am 15.08.2025. Verfasst von Gabriel Amorim Moreira Alves und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Humanitas University, Pieve Emanuele, 20072 Milan, Italy. Hauptthemen laut MEDLINE: Craving, Substance-Related Disorders, Glucagon-Like Peptide 1, Behavior, Addictive. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Substance use disorders (SUDs) remain a major public health challenge, with existing pharmacotherapies offering limited long-term efficacy. Traditional treatments focus on dopaminergic systems but often overlook the complex interplay between metabolic signals, neuroplasticity, and conditioned behaviors that perpetuate addiction. Glucagon-like peptide-1 receptor agonists (GLP-1RAs), originally developed for type 2 diabetes and obesity, have recently emerged as promising modulators of reward-related brain circuits. This review synthesizes current evidence on the role of glucagon-like peptide-1 (GLP-1) and its receptor in modulating craving and substance-seeking behaviors. We highlight how GLP-1 receptors are expressed in addiction-relevant brain regions, including the ventral tegmental area (VTA), nucleus accumbens (NAc), and prefrontal cortex (PFC), where their activation influences dopaminergic, glutamatergic, and GABAergic neurotransmission. In addition, we explore how GLP-1 signaling affects reward processing through gut–brain vagal pathways, hormonal crosstalk, and neuroinflammatory mechanisms. Preclinical studies demonstrate that GLP-1RAs attenuate intake and relapse-like behavior across a range of substances, including alcohol, nicotine, and cocaine. Early-phase clinical trials support their safety and suggest potential efficacy in reducing craving. By integrating findings from molecular signaling, neurocircuitry, and behavioral models, this review provides a translational perspective on GLP-1RAs as an emerging treatment strategy in addiction medicine. We propose that targeting gut–brain metabolic signaling could provide a novel framework for understanding and treating SUDs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CravingSubstance-Related DisordersGlucagon-Like Peptide 1Behavior, AddictiveHumansAnimalsBrainRewardGlucagon-Like Peptide-1 Receptor

Stichwörter der Autor:innen

GLP-1 receptor agonistaddictioncravingdopaminegut–brain axismesolimbic pathwayneuroinflammationreward circuitrysemaglutidesubstance use disordersynaptic plasticityvagal signaling

Substanzen

Glucagon-Like Peptide 1Glucagon-Like Peptide-1 Receptor

Autor:innen und Institutionen

  • Faculty of Medicine, Humanitas University, Pieve Emanuele, 20072 Milan, Italy.
  • Faculty of Medicine and Surgery, University of Milan, 20122 Milan, Italy.
  • Public Health Department, Lummi Nation Tribal Health Center, Bellingham, WA 98226, USA.
  • Emergency Service, GHOL Hôpital de Nyon, 1260 Nyon, Switzerland.

ORCID-Profile: Gabriel Amorim Moreira Alves, Masatoki Teranishi, Arosh S Perera Molligoda Arachchige

Zitieren

APA

Amorim Moreira Alves, G., Teranishi, M., Teixeira de Castro Gonçalves Ortega, A. C., James, F., & Perera Molligoda Arachchige, A. S. (2025). Mechanisms of GLP-1 in Modulating Craving and Addiction: Neurobiological and Translational Insights. Medical Sciences, 13(3), 136. https://doi.org/10.3390/medsci13030136

Vancouver

Amorim Moreira Alves G, Teranishi M, Teixeira de Castro Gonçalves Ortega AC, James F, Perera Molligoda Arachchige AS. Mechanisms of GLP-1 in Modulating Craving and Addiction: Neurobiological and Translational Insights. Medical Sciences. 2025;13(3):136. doi:10.3390/medsci13030136

BibTeX
@article{AmorimMoreiraAlves2025,
  author = {Amorim Moreira Alves, Gabriel and Teranishi, Masatoki and Teixeira de Castro Gonçalves Ortega, Ana Claudia and James, Frank and Perera Molligoda Arachchige, Arosh S},
  title = {Mechanisms of GLP-1 in Modulating Craving and Addiction: Neurobiological and Translational Insights},
  journal = {Medical Sciences},
  year = {2025},
  volume = {13},
  number = {3},
  pages = {136},
  doi = {10.3390/medsci13030136}
}
Kostenlos starten →